SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Geron Corp.
GERN 1.335+2.3%Jan 21 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Lisman who wrote (24)7/30/1997 12:47:00 AM
From: BulbaMan   of 3578
 
I did attend Geron's conference presentation today (onsite at their facility in Menlo Park). In my (somewhat biased) view, they did a great job and Cal Harley and the rest of the team were able to handle some very tough questions from the analysts and portfolio managers present.
I was especially impressed by the slides and data indicating the potential sensitivity of a telomerase-based "universal" cancer diagnostic. Such a diagnostic will undoubtedly be their first product to generate meaningful revenues.
In the more long-term (and incredibly exciting) category, they're making real progress with their primordial stem cell program. John Gearhart of John Hopkins, who just isolated the first human primordial stem cell, is a Geron collaborator and my guess is Geron will soon acquire a license for Gearhart's cells.
They're, of course, also continuing their work on developing a telomerase inhibitor compound for cancer treatment as well as studying cell senescence and gene expression.
I left Geron feeling more confidence in the company and its scientific team and convinced that the stock at its current price under $7 doesn't reflect the company's technology and patent portfolio. Once biotech stocks come back in favor (when, oh when?), I think Geron should move significantly higher.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News